N3-(2,6-dichlorophenyl)-1-(2-(4-methylpiperazin-1-yl)ethyl)-N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine | 1099657-03-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡唑并嘧啶类
• 英文名称: N3-(2,6-dichlorophenyl)-1-(2-(4-methylpiperazin-1-yl)ethyl)-N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine
• 英文别名: 3-N-(2,6-dichlorophenyl)-1-[2-(4-methylpiperazin-1-yl)ethyl]-6-N-phenylpyrazolo[3,4-d]pyrimidine-3,6-diamine
• CAS: 1099657-03-0
• 化学式: C₂₄H₂₆Cl₂N₈
• 分子量: 497.43
• InChiKey: WIDBVENAQSOJEN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  34
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  74.1
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  6-chloro-N-(2,6-dichlorophenyl)-1-(2-(4-methylpiperazin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-amine 、 苯胺 在 三氟乙酸 作用下， 以 1,4-二氧六环 为溶剂， 生成 N3-(2,6-dichlorophenyl)-1-(2-(4-methylpiperazin-1-yl)ethyl)-N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine
  参考文献：
  名称：

  Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors

  摘要：

  A new series of pyrazolo[3,4-d]pyrimidine-3,6-diamines was designed and synthesized as potent and selective inhibitors of the nonreceptor tyrosine kinase, ACK1. These compounds arose from efforts to rigidify an earlier series of N-aryl pyrimidine-5-carboxamides. The synthesis and structure-activity relationships of this new series of inhibitors are reported. The most promising compounds were also profiled for their pharmacokinetic properties.

  DOI：

  10.1016/j.bmcl.2008.10.092

文献信息

• Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors
  作者：David J. Kopecky、Xiaolin Hao、Yi Chen、Jiasheng Fu、XianYun Jiao、Juan C. Jaen、Mario G. Cardozo、Jinsong Liu、Zhulun Wang、Nigel P.C. Walker、Holger Wesche、Shyun Li、Ellyn Farrelly、Shou-Hua Xiao、Frank Kayser

  DOI：10.1016/j.bmcl.2008.10.092

  日期：2008.12

  A new series of pyrazolo[3,4-d]pyrimidine-3,6-diamines was designed and synthesized as potent and selective inhibitors of the nonreceptor tyrosine kinase, ACK1. These compounds arose from efforts to rigidify an earlier series of N-aryl pyrimidine-5-carboxamides. The synthesis and structure-activity relationships of this new series of inhibitors are reported. The most promising compounds were also profiled for their pharmacokinetic properties.